Post Tagged with: "cost-effectiveness"

Allergen-Specific Immunotherapy

Allergen-Specific Immunotherapy

*Esther Helen Steveling-Klein Department of Dermatology and Allergology, University Hospital Basel, Basel, Switzerland *Correspondence to esthersteveling@gmail.com Disclosure: Esther Helen Steveling-Klein received travel support from ALK-Abello. Received: 17.05.16 Accepted: 08.08.16 Citation: EMJ. 2016;1[4]:78-87. Abstract Allergen-specific immunotherapy remains the only causal treatment of allergic disease to date. Its efficacy in symptom reductionRead More

GreenLight XPS™ Vaporisation of the Prostate Has Proven Cost-Effective

GreenLight XPS™ Vaporisation of the Prostate Has Proven Cost-Effective

Urology October 10, 2016 at 9:41 AM 0 comments

*Gordon Muir,1 Neil Barber,2 James Andrew Thomas,3 Simone Giona1 1. King’s College Hospital, London, UK 2. Frimley Park Hospital, London, UK 3. Princess of Wales Hospital, Bridgend, UK *Correspondence to gordon@london-urology.co.uk Disclosure: Gordon Muir has received speaker and mentoring fees from Boston Scientific and Neotract. Neil Barber has received speaker andRead More

Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France

Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France

Cardiology February 24, 2015 at 9:50 AM 0 comments

*Lieven Annemans,1 Johanne Silvain,2 Gilles Montalescot2,3 1. I-CHER Interuniversity Centre for Health Economics Research, Ghent University,  Department of Public Health, Gent, Belgium 2. Department of Cardiology, CHU La Pitié-Salpêtrière (AP-HP), Paris, France; ACTION study group 3. University of Paris, Paris, France *Correspondence to lieven.annemans@ugent.be Disclosure: L.A. is a consultant toRead More

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

Hepatology May 27, 2014 at 11:37 AM 0 comments

*Mehlika Toy Asian Liver Center and Department of Surgery, Stanford School of Medicine, Stanford; Department of Global Health and Population, Harvard School of Public Health, Boston, USA *Correspondence to mtoy@hsph.harvard.edu Disclosure: No potential conflict of interest. Received: 24.12.13 Accepted: 13.03.14 Citation: EMJ Hepatol. 2014;1:71-76. Abstract The hepatitis B virus (HBV)Read More